Cargando…
Association Between Genetically Proxied Lipid-Lowering Drug Targets and Renal Cell Carcinoma: A Mendelian Randomization Study
Observational studies suggested inconsistent associations between lipid-lowering drugs, such as statins, and renal cell carcinoma (RCC) risk. In a two-sample Mendelian randomization (MR) framework, we assessed the causal influence of lipid-lowering agents and circulating lipid traits on overall and...
Autores principales: | Liu, Luyang, Sheng, Chao, Lyu, Zhangyan, Dai, Hongji, Chen, Kexin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545796/ https://www.ncbi.nlm.nih.gov/pubmed/34712689 http://dx.doi.org/10.3389/fnut.2021.755834 |
Ejemplares similares
-
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis
por: Yarmolinsky, James, et al.
Publicado: (2023) -
Genetic association of lipids and lipid-lowering drugs with sepsis: a Mendelian randomization and mediation analysis
por: Lou, Chen, et al.
Publicado: (2023) -
Coffee and caffeine consumption and risk of renal cell carcinoma: A Mendelian randomization study
por: Li, Bing-Hui, et al.
Publicado: (2022) -
Causal association of polyunsaturated fatty acids with chronic pain: a two-sample Mendelian randomization study
por: Dai, Yuxuan, et al.
Publicado: (2023) -
BMI and plasma lipid levels with risk of proliferative diabetic retinopathy: a univariable and multivariable Mendelian randomization study
por: Shu, Yiyang, et al.
Publicado: (2023)